Skip to main content
main-content

Neuer Inhalt Free registration

Gain full access to the latest clinical content available from Springer Nature

Editors' pick

11-21-2017 | Prevention | News

Oral insulin fails to delay type 1 diabetes in high-risk population

Giving daily oral insulin to high-risk relatives of patients with type 1 diabetes did not delay the onset of the condition in the Type 1 Diabetes TrialNet Oral Insulin Study, although the investigators say that doubts surrounding the dose of insulin used means the case is not yet closed.

11-22-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

Metabolically healthy obesity: Laying a controversial concept to rest

The concept of metabolically healthy obesity has produced huge numbers of seemingly contradictory studies, and polarized opinion among researchers. medwireNews looks back at the big data, the high-impact publications, and the underlying hypotheses that helped the concept to persist for so long, and asks if the field has finally reached consensus.

Latest from across the site

11-24-2017 | Prevention | News

QDiabetes risk model updated

The QDiabetes risk assessment tool for type 2 diabetes has been updated with an expanded range of risk factors and additional models that incorporate blood glucose tests.

Source:

BMJ 2017; 359: j5019

11-23-2017 | Cardiovascular outcomes | News

Intensive diabetes treatment reduces CVD risk even with excessive weight gain

Intensive treatment of type 1 diabetes appears to reduce the risk for cardiovascular disease events even in those who gain excessive weight, but improved management of cardiovascular risk factors and revascularization may be needed.

Source:

Diabetes Care 2017; Advance online publication

11-22-2017 | Adolescents | News

Peer support influences outcomes for youths with type 1 diabetes

Peer and parental support are important factors influencing diabetes-related distress among adolescents and young adults with type 1 diabetes, researchers report.

Source:

Diabetes Care 2017; Advance online publication

11-22-2017 | Cardiovascular disorders | Editorial | Article

Diabetes in special situations: Sodium-glucose co-transporter-2 inhibitors in acute coronary syndrome

Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of sodium-glucose co-transporter-2 inhibitors in patients affected by acute coronary syndromes.

Author:
Sanjay Kalra MBBS, MD, DM

11-21-2017 | Prevention | News

Oral insulin fails to delay type 1 diabetes in high-risk population

Giving daily oral insulin to high-risk relatives of patients with type 1 diabetes did not delay the onset of the condition in the Type 1 Diabetes TrialNet Oral Insulin Study, although the investigators say that doubts surrounding the dose of insulin used means the case is not yet closed.

Source:

JAMA 2017; 318: 1891–1902

11-20-2017 | Prediabetes | News

1-hour blood glucose level improves prediction of future type 2 diabetes

A blood glucose level taken 1 hour after glucose loading better predicts future type 2 diabetes risk than the level taken at 2 hours, long-term study findings indicate.

Source:

Diabetes Care 2017; Advance online publication

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John WildingCarol Wysham

New Content Item Meet our Advisory Board

image credits